Skip to main content
. 2019 Oct 8;75(7):1346–1352. doi: 10.1093/gerona/glz233

Table 3.

Odds of Developing Incident Mobility Limitations in Men Aged 55 Years and Older

Model 1* Model 2**
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Associated w/ Baseline Associated w/ Change§ Associated w/ Baseline Associated w/ Change§
Grip Strength, per 5 kg

0.83

(0.71–0.96)

1.00 0.81 0.92
(0.84–1.20) (0.69–0.95) (0.76–1.13)
Grip Strength, per SD 0.69 1.00 0.67 0.90
(0.52–0.92) (0.79–1.27) (0.49–0.90) (0.69–1.17)
Grip Strength/BMI 0.50 1.05 0.47 0.86
(0.37–0.68) (0.83–1.33) (0.34–0.66) (0.65–1.13)
ALMBMI 0.63 0.81 0.55 0.68
(0.48–0.83) (0.65–1.01) (0.41–0.73) (0.53–0.87)
ALM/ht2† 1.36 0.75 1.25 0.81
(1.04–1.77) (0.60–0.95) (0.94–1.65) (0.63–1.03)
FNIH Cut Points
Low ALMBMI, n = 5 (0.7%) 4.37 (0.43–43.91)
Weakness, n = 8 (1.1%) 2.83 (0.60–13.39)
Weakness/BMI, n = 19 (2.6%) 4.01 (1.40–11.47)
Low ALMBMI plus Weakness, n = 0 N/A
European Working Group Cut Points
Low ALM/ht2 (EWGSOP2), n = 8 (1.1%) 1.27 (0.12–13.27)
Weakness (EWGSOP2), n = 17 (2.3%) 3.03 (1.0–9.18)
Low ALM and Weakness, n = 2 (0.3%) 15.09 (0.71–320.09)

Note: SD = Standard deviation; OR = Odds ratio; BMI = Body mass index; ALM = Appendicular lean mass; FNIH = Foundations for the National Institutes of Health; EWGSOP2 = European Working Group for Sarcopenia in Older People 2.

*Model 1 is adjusted for age, hypertension, diabetes and arthritis/gout;

**Model 2 is Model 1 but includes both baseline and change in the sarcopenia parameter;

§This column depicts the association between concurrent change in each sarcopenia characteristic, and incident mobility limitations after 6 years;

Odds ratios and 95% confidence intervals are expressed per standard deviation (values in Supplementary Table S3, all column).